Nexipox Vaccine 0.5ml Injection

The Nexipox Vaccine 0.5ml Injection is a freeze-dried vaccine indicated for active immunization against chickenpox (varicella) in individuals 12 months of age and older. This vaccine contains a live attenuated varicella-zoster virus (Oka strain), designed to stimulate the immune system to produce antibodies and provide protection against future infections.

Administered by a healthcare professional, the vaccine is typically given as a subcutaneous injection, specifically at the deltoid insertion area of the lateral aspect of the upper arm. The dosing schedule involves two doses; for children aged 12 months to 12 years, the second dose is given at least 3 months after the first, while for adolescents and adults, the two doses are administered a minimum of 4 weeks apart.

Maintaining the vaccine's integrity requires strict cold-chain storage in a refrigerator at 2°C to 8°C, with protection from light, and it must not be frozen. As a freeze-dried preparation, it necessitates reconstitution with a sterile diluent prior to use, and the reconstituted vaccine should be used immediately, discarding any unused portion after 30 minutes. The Nexipox Vaccine has received regulatory approval from the Drugs Controller General of India (DCGI).

Key Features : 

Antigen Composition: Contains live attenuated varicella-zoster virus (Oka strain) for active immunization against chickenpox.
Approved Indications: Indicated for the prevention of chickenpox in individuals 12 months of age and older.
Cold-chain Storage: Requires storage in a refrigerator at 2°C to 8°C, must not be frozen, and should be protected from light.
Route of Administration: Administered via subcutaneous injection, typically in the deltoid area of the upper arm.
Dosing Schedule: Administered in two doses; for children 12 months to 12 years, doses are at least 3 months apart, and for adolescents and adults, doses are a minimum of 4 weeks apart.
Regulatory Approval: Approved by the Drugs Controller General of India (DCGI).
Reconstitution Requirements: The freeze-dried vaccine must be reconstituted with the provided sterile diluent and used immediately, discarding if not used within 30 minutes.